Nano Drug Delivery Systems for Colon Cancer

Arun Kumar Singh is Assistant Professor in the Department of Pharmacy at Vivekanand Global University, India. His teaching and research activities span pharmaceutical sciences and a range of interdisciplinary fields, including nanoformulation, cancer biology, artificial intelligence, machine learning, blockchain technology, the Internet of Things, big data analytics, and neuroscience. He has contributed to scholarly publishing through authorship and editorial work and has participated in research and academic initiatives that integrate emerging technologies with healthcare and pharmaceutical applications. His interests focus on advancing innovative approaches to drug delivery, biomedical research, and technology-enabled solutions for healthcare challenges. Dr. Vipan Kumar is an Associate Professor at the School of Pharmaceutical Sciences, CGC University, Mohali, India. He received his PhD in Pharmaceutical Sciences from Maharshi Dayanand University, Rohtak, India, where he was awarded fellowship support from the University Grants Commission (UGC), New Delhi. Dr. Kumar’s research focuses on medicinal chemistry, nanotechnology-based drug delivery, and the development of novel therapeutic agents for cancer and metabolic disorders. Dr. Kumar has published over 35 research and review articles in peer-reviewed national and international journals and has authored and edited 04 national and international books, along with several book chapters. He also holds 04 Indian patents in the areas of drug discovery and nanomedicine. His academic achievements have been recognized with several honors, including the Backbone Award (2025–26) from CGC University, Mohali, and the Devi Lal Memorial Award (2020–21) from JCD Vidyapeeth, Sirsa, for excellence in teaching and research. Dr. Kumar serves on the editorial boards of multiple international journals and acts as a reviewer for several reputed publications. He has delivered more than 30 oral and poster presentations at national and international scientific meetings and actively contributes to academic governance and policy development through his roles in ethical committees, inspection teams, examination committees, and university Boards of Studies.Pranav Kumar Prabhakar is Professor and Head of the Department of Biotechnology, School of Engineering and Technology, Nagaland University, Kohima, India. His research focuses on understanding molecular mechanisms involved in metabolic disorders, particularly diabetes, and on developing strategies for oral insulin delivery using natural products and biotechnology-based approaches. He is actively involved in research, academic mentoring, peer review, and editorial activities within the biomedical and biotechnology fields. His professional interests include translational research, signaling pathways associated with metabolic diseases, and the application of biotechnology to improve therapeutic outcomes. He contributes to scientific and academic initiatives that support advancements in biotechnology and healthcare research. Dr. Meenakshi Dhanawat is an Associate Professor at the Amity Institute of Pharmacy, Amity University Haryana, with many years of experience in Pharmaceutical Sciences and Medicinal Chemistry. She completed her Master's degree at NIPER, Mohali, focusing on glycosylamino acids, and earned her Ph.D. from IIT-BHU, Varanasi, investigating CNS drug delivery targeting 5HT1A/2A receptors. Her research encompasses synthetic and heterocyclic chemistry, nanotechnology, drug delivery systems, prodrug design, complexation, polymer chemistry, and herbal drug extraction. Dr. Dhanawat has received notable international recognition, including a travel grant from the AAPS Drug Delivery and Development section for the 2010 National Biotechnology Conference in California, and international travel grants from DBT and DST, Government of India, for conferences in California and Munich. Her distinguished honors include the Rajiv Gandhi National Fellowship, affirming her sustained contributions to pharmaceutical research and academic excellence. Neeraj Mishra is Professor and Head of the Department of Pharmaceutics at the Amity Institute of Pharmacy, Amity University Madhya Pradesh, Gwalior, India. His academic work focuses on novel drug delivery systems, including localized, targeted, and controlled delivery approaches using nanocarrier and microparticle-based technologies. His research interests encompass therapies for cancer and neurodegenerative disorders, and he has extensive experience in teaching, research supervision, and scholarly publishing. He has also contributed to innovation in pharmaceutical sciences through intellectual property development and collaborative academic activities. Through his research and educational initiatives, he supports the advancement of drug delivery strategies and pharmaceutical research.

• 1. Etiology and pathophysiology of colon cancer2. Current trends of targeted nanoparticulate carriers for the treatment of colon cancer3. Lipid nanocarrier-based drug delivery for the treatment of colon cancer4. Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy5. siRNA polymer conjugates for the delivery of RNAi therapeutics for the treatment of Colon Cancer6. Carbon-Based Quantum Dots and Nanotubes for Colon Cancer Targeting and Drug Delivery7. Recent trends of extracellular vesicles for therapeutic intervention of Colon Cancer8. Mitochondria-targeted drug delivery systems for the effective treatment of colon cancer9. Revolutionizing Colon Cancer Care: Advances in Carbon-Based Materials as theranostic agents10. Surface modified Metal Nanoparticles in Colon Cancer Therapy11. Nano-based Phyto drug delivery systems for the management of colon cancer12. Role of polymeric nanoparticles for the treatment of Colon cancer13. Nanomicelles based drug delivery systems as for targeted therapy of colon cancer14. Regulatory framework in the Nanomedicine targeting Colon Cancer15. Current and future perspectives of nanomedicine in colon cancer treatment

Select Guide Rating